Scientists hunt genetic clues to personalize breast cancer prevention

NCT ID NCT06062810

Summary

This study aims to understand how a person's genes affect their response to the drug raloxifene, which is used to reduce breast cancer risk in people with a condition called LCIS. Researchers will analyze genetic data from 600 patients to see if specific gene variations predict how well the drug works or what side effects they might have. The goal is to gather knowledge that could one day help doctors personalize treatment, but this study itself does not test a new treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Medicine Invention Design, Inc. - IORG0007849 - NPI 1023387701

    Rockville, Maryland, 20853, United States

Conditions

Explore the condition pages connected to this study.